Stay updated on Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial
Sign up to get notified when there's something new on the Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial page.

Latest updates to the Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision metadata was updated from v3.6.4 to v3.6.5, indicating a newer version of the page content. This update represents a refreshed deployment of the page without changing the study details.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedA minor site revision number was updated from v3.6.3 to v3.6.4 in the page footer. This signals a backend or UI update rather than changes to the study details.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page now displays Revision: v3.6.3 instead of v3.6.2. This change is limited to the version label and does not modify the underlying study information or user experience.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2, indicating a minor build update to the page. The content and function of the study details page remain the same.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page adds a recruitment notice 'No longer looking for participants' and introduces new help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a formatting update to the Intervention/Treatment heading, and the site revision is updated to v3.6.0.SummaryDifference0.4%

- Check82 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, reflecting a minor page system update. It does not change the study data, eligibility criteria, or results on the page, only the page's revision label.SummaryDifference0.0%

Stay in the know with updates to Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial page.